Remote Brain Microhaemorrhages May Predict Haematoma in Glioma Patients Treated With Radiation Therapy

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT03973892

Enrollment

Registered

2019-06-04

Start date

2015-01-31

Completion date

2016-01-31

Last updated

2019-06-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Glioma

Brief summary

the study aim to evaluate the prevalence of cerebral remote microhaemorrhages (RMH) and remote haematomas (RH) using magnetic resonance susceptibility-weighted imaging (SWI) among patients treated for gliomas during follow-up.

Interventions

DIAGNOSTIC_TESTCere

Magnetic Rseonance imaging for brain tumour follow-up

Study design

Observational model

COHORT

Time perspective

RETROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* glioma

Exclusion criteria

Design outcomes

Primary

Measure	Time frame
number of microhaemorrhages (RMH) on magnetic resonance imaging	one year
number of remote haematomas (RH) on magnetic resonance imaging	one year

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026